Track developments
Monitor relevant company, clinical, regulatory, manufacturing, partnership and investment activity.
BioSignalIQ™
BioSignalIQ™ tracks relevant company and market developments, shows why they matter commercially and helps teams focus on the accounts with the strongest timing and fit.
BioSignalIQ™ brings priority shifts, supporting signals and recommended focus into one decision view.
Monitor relevant company, clinical, regulatory, manufacturing, partnership and investment activity.
Understand why each development may matter commercially.
Compare opportunities using consistent scoring and timing.
See recommended next steps for the accounts that matter.
Use the workspace navigation to review the opportunity outlook, signal records, ranked accounts and market dashboard.
Account priorities are connected to the developments, evidence, timing shifts and actions underneath them.
Explore how account priorities, signal intelligence and market analytics connect inside the product.
Dynamic ranking by relevance, timing and supporting evidence.
Chronological developments and their commercial interpretation.
See how BioSignalIQ™ connects account movement, supporting signals and commercial timing. A guided demo walks through the complete evidence trail, scoring logic and account-level detail.
Facility activity was added to an already active late-stage program.
Reinforcing operational signals moved likely engagement timing into the near-term window.
Facility scope, validation hiring and supplier-selection activity.
Review full evidence, score history, commercial timing and recommended action using a workspace configured around your market.
BioSignalIQ™ evaluates each development against your offering, target accounts and commercial priorities, so the same signal can mean something different for a CDMO, CRO, equipment supplier or technology provider.
Late-stage clinical progress
Potential process development, scale-up or manufacturing requirement.
New clinical program or regulatory clearance
Potential trial execution or specialist clinical-support requirement.
New manufacturing facility or capacity expansion
Potential process-equipment or facility-technology requirement.
Technology transfer or workflow standardization
Potential platform, validation or workflow-technology requirement.
Each priority combines evidence quality, signal strength, engagement timing, product / service fit and strategic fit. The components remain visible so teams can understand what moved and why.
Confirm the project timetable and identify the stakeholders responsible for engineering, manufacturing and procurement decisions.
Every scoring component remains visible in the account record.
BioSignalIQ™ keeps the source record and commercial interpretation distinct, so teams can verify what happened before acting on why it matters.
This is the factual development recorded from the source.
This is the BioSignalIQ™ interpretation, shown separately from the source statement.
Explore the workspace or schedule a guided demo to see how BioSignalIQ™ can be configured around your customers, products and commercial priorities.